Mission: improve #LungCancer outcomes by funding research for the prevention, diagnosis, treatment and cure of lung cancer | #MedSky #OncSky
Lung Cancer Research Foundation
Loading...
Get organized by making a plan that reflects your wishes to protect the people you love and support for LCRF. Create or update your will with our trusted partner, FreeWill, in just 20 minutes at no cost: frwill.link/lcrf_spring26
Are you going to the ASCO Annual Meeting in Chicago? LCRF will be there this weekend! Visit us at the ASCO-Sponsored Patient Advocacy Booth (#13000) from May 30 - June 1. We'd love to share our #LungCancer resources and information with you.
Scientists from the Francis Crick Institute in the UK were able to predict who would develop lung cancer more accurately than the best risk assessment models currently in use through identifying a set of proteins in the blood. From the NYT: buff.ly/xZI1UdV
LCRF and AstraZeneca announced that two research awards focused on improving outcomes for people with small cell #LungCancer (SCLC) are now open for investigator submissions. One award focuses on improving treatment; the other on improving the outcomes through patient advocacy. LCRF.org/sclc-rfp
Dr. Jalal Ahmed recently published his LCRF-funded work on CAR T-cell therapy in #LungCancer. LCRF's Chief Scientific Officer, Dr. Antoinette Wozniak, explains the science of CAR T-cells and how this type of therapy can impact patient outcomes. LCRF.org/sms2664
LCRF has announced a new research award focused on accelerating treatment options for people with ALK fusion-driven non-small cell #LungCancer is now open for investigator submission. This new grant was made possible through generous support from our community. LCRF.org/alk-rfp
We’re proud to announce our Women & Lung Cancer video event with Dr. Isabel Preeshagul and Dr. Narjust Florez. This is a compilation of highlights from our webinars on women and lung cancer over the past five years. Watch now! LCRF.org/women#video
#LungCancer #WLC #Women
LCRF, in partnership with patients, survivors, caregivers, loved ones, industry partners and medical leaders, is funding two $300,000 two-year awards to accelerate treatment options for people with ALK positive NSCLC Read more about this collaborative effort. buff.ly/y5mA3NV
LCRF's spring e-news is out! If it's not in your inbox, catch up on grants, RFPs, Science Made Simple, Connecting the Dots, ASCO happenings and more at LCRF.org/enews. (And be sure to subscribe: LCRF.org#subscribe)
#LungCancer #InTheNews
#LungCancer investigators: LOIs are being accepted for 3 new grant mechanisms. A $300K 2yr award supports ALK+ NSCLC research. LCRF & AstraZeneca partnered on two SCLC-focused grants: a $500K 3yr award on treatments & a $250, 2yr award to improve outcomes through patient advocacy. LCRF.org/funding
Lung Cancer Research Foundation
Lung Cancer Research Foundation
Lung Cancer Research Foundation
Lung Cancer Research Foundation
Lung Cancer Research Foundation
Lung Cancer Research Foundation
Lung Cancer Research Foundation
Lung Cancer Research Foundation
Lung Cancer Research Foundation
Lung Cancer Research Foundation
The good news Jalal Ahmed MD, PhD, an Assistant Professor at the Precision Immunology Institute, Department of Radiation Oncology, Icahn School of Medicine, Mount Sinai in New York City, has […]
